KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Staar Surgical (STAA) Shares Outstanding (2021 - 2026)

Staar Surgical (STAA) has disclosed Shares Outstanding for 15 consecutive years, with $49.8 million as the latest value for Q1 2026.

  • For the quarter ending Q1 2026, Shares Outstanding rose 0.98% year-over-year to $49.8 million, compared with a TTM value of $49.8 million through Jan 2026, up 0.98%, and an annual FY2026 reading of $49.8 million, up 0.98% over the prior year.
  • Shares Outstanding was $49.8 million for Q1 2026 at Staar Surgical, roughly flat from $49.7 million in the prior quarter.
  • Across five years, Shares Outstanding topped out at $49.8 million in Q1 2026 and bottomed at $47.8 million in Q2 2022.
  • Average Shares Outstanding over 5 years is $48.9 million, with a median of $49.0 million recorded in 2023.
  • The sharpest move saw Shares Outstanding increased 2.03% in 2022, then increased 0.78% in 2025.
  • Year by year, Shares Outstanding stood at $48.2 million in 2022, then rose by 1.3% to $48.8 million in 2023, then rose by 0.93% to $49.3 million in 2024, then increased by 0.88% to $49.7 million in 2025, then rose by 0.1% to $49.8 million in 2026.
  • Business Quant data shows Shares Outstanding for STAA at $49.8 million in Q1 2026, $49.7 million in Q3 2025, and $49.5 million in Q2 2025.